Dr. Arvind Ramachandrarao Cavale, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4 Rose Ave, Suite A, Feasterville Trevose, PA 19053 Phone: 215-953-6804 Fax: 215-953-6635 |
Ayesha Parvez, M.D Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 210 E Street Rd, Suite 3e, Feasterville Trevose, PA 19053 Phone: 215-953-6804 Fax: 215-953-6635 |
News Archive
On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it.
The President's Emergency Plan for AIDS Relief program has suspended funding for three antiretroviral drugs manufactured by Indian generic drugmaker Ranbaxy that were included in an importation ban imposed by FDA on Sept. 16, Bloomberg reports.
Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and obtained the Certificate for the Release of Biological Products, which means the released vaccines are ready for delivery.
Mayo Clinic researchers report that most women who have a contralateral (opposite to cancerous breast) prophylactic mastectomy (CPM) are satisfied and would elect this procedure again. Satisfaction with CPM was studied an average of 10 years after the procedure was done. The findings were published online Oct. 3 in the Journal of Clinical Oncology.
› Verified 5 days ago